{
  "id": "cluster_23_doc2",
  "content": "April 2024 provider bulletin announced expanded coverage for IV immunoglobulin (Gammagard) at Tier 2 copay when prescribed by board-certified immunologists for myasthenia gravis patients. This change applies specifically to members in Southern California regions. Claims must include treatment frequency documentation and physician NPI# 1234567890 for eligibility verification.",
  "metadata": {
    "format": "policy_document"
  }
}